Home Synthesis and crystal structure of 2-((1-phenyl-3-(thiophen-2-yl)-1H-pyrazol-4-yl)methylene)-2,3-dihydro-1H-inden-1-one, C23H16N2OS
Article Open Access

Synthesis and crystal structure of 2-((1-phenyl-3-(thiophen-2-yl)-1H-pyrazol-4-yl)methylene)-2,3-dihydro-1H-inden-1-one, C23H16N2OS

  • Alaa Alqahtani , Bakr F. Abdel-Wahab , Amany S. Hegazy , Benson M. Kariuki EMAIL logo and Gamal A. El-Hiti EMAIL logo
Published/Copyright: May 17, 2019

Abstract

C23H16N2OS, orthorhombic, Pna21 (no. 33), a = 19.4988(9) Å, b = 19.5060(9) Å, c = 9.2893(4) Å, V = 3533.1(3) Å3, Z = 8, Rgt(F) = 0.0501, wRref(F2) = 0.1269, T = 296(2) K.

CCDC no.: 1910861

The asymmetric unit containing two crystallogaphically independent molecules is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Yellow plate
Size:0.55 × 0.38 × 0.12 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.20 mm−1
Diffractometer, scan mode:SuperNova, ω
θmax, completeness:29.7°, >99%
N(hkl)measured, N(hkl)unique, Rint:17282, 7967, 0.039
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 5569
N(param)refined:533
Programs:CrysAlisPRO [1], SHELX [2], [3], WinGX/ORTEP [4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
N10.81811(13)0.74789(15)0.8462(3)0.0400(7)
N20.83674(13)0.81117(15)0.7963(3)0.0398(7)
N30.06260(14)0.75158(16)0.8479(3)0.0431(7)
N40.08813(14)0.81248(15)0.7989(3)0.0428(7)
O11.04235(14)0.63547(14)0.3821(4)0.0601(8)
O20.29649(15)0.62024(15)0.4201(3)0.0622(8)
C10.99248(16)0.73792(18)0.4836(4)0.0384(8)
C21.03887(17)0.69742(19)0.3894(4)0.0427(8)
C31.07935(16)0.74778(19)0.3062(4)0.0408(8)
C41.12964(19)0.7355(2)0.2039(4)0.0485(10)
H41.1431090.6909720.1819150.058*
C51.1592(2)0.7909(2)0.1356(4)0.0533(11)
H51.1926870.7838070.0658360.064*
C61.1393(2)0.8566(2)0.1704(5)0.0521(10)
H61.1599640.8934000.1237760.063*
C71.08948(19)0.8691(2)0.2729(4)0.0494(9)
H71.0762040.9137120.2946730.059*
C81.05960(17)0.81350(19)0.3428(4)0.0411(8)
C91.00469(17)0.81295(18)0.4578(4)0.0400(8)
H9A1.0205110.8355160.5447300.048*
H9B0.9632760.8354310.4243530.048*
C100.94833(17)0.70713(19)0.5740(4)0.0409(8)
H100.9480540.6594660.5713390.049*
C110.90116(17)0.73834(19)0.6748(4)0.0375(8)
C120.85655(16)0.70380(17)0.7736(4)0.0377(8)
C130.88595(17)0.80659(19)0.6949(4)0.0410(8)
H130.9061560.8432100.6468710.049*
C140.84909(17)0.63101(18)0.8031(4)0.0408(8)
C150.89497(19)0.57704(18)0.7839(4)0.0459(9)
H150.9382320.5817960.7429410.055*
C160.8680(2)0.5143(2)0.8339(5)0.0583(11)
H160.8920660.4731950.8305010.070*
C170.8038(2)0.5199(2)0.8871(5)0.0603(11)
H170.7786100.4832580.9233640.072*
S10.77468(5)0.60175(6)0.87961(14)0.0585(3)
C180.80614(17)0.87052(18)0.8567(4)0.0430(8)
C190.7736(2)0.8670(2)0.9871(5)0.0535(10)
H190.7704560.8252331.0349120.064*
C200.7456(2)0.9247(3)1.0477(5)0.0655(12)
H200.7239370.9219031.1366780.079*
C210.7493(2)0.9862(2)0.9781(6)0.0689(13)
H210.7305261.0252921.0195620.083*
C220.7808(3)0.9899(2)0.8474(7)0.0816(16)
H220.7830781.0317730.7998570.098*
C230.8095(2)0.9327(2)0.7842(6)0.0660(13)
H230.8306420.9356700.6947200.079*
C240.24134(17)0.7250(2)0.5006(4)0.0431(9)
C250.28958(18)0.6827(2)0.4147(4)0.0470(9)
C260.32794(17)0.7300(2)0.3212(4)0.0431(9)
C270.3787(2)0.7156(2)0.2204(4)0.0513(10)
H270.3923920.6707100.2028230.062*
C280.4082(2)0.7695(2)0.1471(4)0.0562(11)
H280.4425750.7610790.0799390.067*
C290.3870(2)0.8361(2)0.1732(5)0.0567(11)
H290.4070640.8719150.1222120.068*
C300.33686(19)0.8505(2)0.2727(5)0.0534(10)
H300.3232060.8954740.2894770.064*
C310.30698(17)0.79674(19)0.3478(4)0.0432(8)
C320.25205(17)0.79913(19)0.4622(4)0.0434(9)
H32A0.2672130.8252560.5451350.052*
H32B0.2101980.8193510.4249840.052*
C330.19715(18)0.6974(2)0.5946(4)0.0450(9)
H330.1980580.6499300.6027920.054*
C340.14812(18)0.7329(2)0.6848(4)0.0430(9)
C350.09869(17)0.70368(18)0.7799(4)0.0416(8)
C360.13895(18)0.8023(2)0.7014(4)0.0453(9)
H360.1633940.8364330.6539630.054*
C37a0.0847(7)0.6312(2)0.8080(9)0.0446(12)
C38a0.0840(6)0.5769(5)0.7127(12)0.059(3)
H38a0.0934640.5806540.6148920.071*
C39a0.0670(4)0.5145(3)0.7834(7)0.0597(14)
H39a0.0673620.4720510.7376180.072*
C40a0.0503(4)0.5228(3)0.9233(7)0.0645(16)
H40a0.0365760.4873400.9836760.077*
S2a0.05747(9)0.60634(9)0.97576(18)0.0614(6)
C37Ab0.079(4)0.6351(7)0.827(5)0.054(4)
C38Ab0.043(2)0.6150(12)0.949(3)0.058(4)
H38Ab0.0205520.6446941.0115040.069*
C39Ab0.0464(19)0.5426(11)0.967(2)0.058(4)
H39Ab0.0384160.5202151.0537830.070*
C40Ab0.062(2)0.5100(9)0.843(3)0.055(4)
H40Ab0.0561630.4633690.8270590.066*
S2Ab0.0954(9)0.5655(8)0.7204(16)0.061(3)
C410.06147(18)0.8750(2)0.8532(4)0.0454(9)
C420.0016(2)0.8749(2)0.9313(5)0.0541(10)
H42−0.0226480.8342720.9440710.065*
C43−0.0224(2)0.9354(2)0.9911(6)0.0654(12)
H43−0.0629480.9354251.0439240.079*
C440.0130(3)0.9946(2)0.9728(6)0.0702(13)
H44−0.0024661.0346581.0164490.084*
C450.0718(2)0.9960(2)0.8899(6)0.0714(14)
H450.0949761.0370230.8751700.086*
C460.0960(2)0.9361(2)0.8289(5)0.0581(11)
H460.1352490.9367290.7719180.070*
  1. aOccupancy: 0.831(5), bOccupancy: 0.169(5).

Source of material

The title compound was synthesized based on a literature procedure from reaction of equimolar amounts of 1-phenyl-3-(thiophen-2-yl)-1H-pyrazole-4-carbaldehyde and 2,3-dihydro-1H-inden-1-one in boiling ethanol containing few drops of piperidine as catalyst for 2 h [5]. Crystallization of the solid obtained using dimethylformamide gave colorless crystals of the title compound (87%).

Experimental details

All hydrogen atoms were placed in calculated positions and refined using a riding model. Aromatic C—H distances were set to 0.93 Å (AFIX 43 instruction in SHELXL [2], [3]) and their Uiso set to 1.2 times the Ueq(C). Methylene C—H distances were set to 0.97 Å and their Uiso to 1.2 times the Ueq(C) (AFIX 23). Crystal data, data collection and structure refinement details are summarized in Table 1.

Comment

Pyrazoles exhibit a wide range of biological activities and can be used as therapeutic agents such as celecoxib, rimonabant, difenamizole, betazole, and fezolamide [6], [7], [8], [9], [10]. Therefore, synthesis of heterocycles containing pyrazole ring systems is always important [11], [12], [13].

The molecule of the title compound comprises indanone (A), pyrazolyl (B), phenyl (C) and thiophenyl (D) ring systems. The asymmetric unit consists of two independent molecules: 1 (C1—C23) and 2 (C24—C46). The thiophenyl group is disordered in molecule 2 by a rotation of 180° about the Cthiophene–Cpyrazole bond with component occupancies of 0.83(1) and 0.17(1). The twist angles between the planes through rings A–B, B–C, B–D are 2.3(1)°, 19.1(2)°, 23.0(2)° for molecule 1 and 5.4(2)°, 13.8(2)°, 34.4(3)° for molecule 2. Bond lengths and angles are in the typical ranges [14].

In the structure, molecules 1 and 2 are arranged in pairs with indanone centroid-centroid separation of 4.87 Å. The pairs of molecules are stacked to form columns parallel to [100]. Neighbouring columns are related by translation along [001] and by 21 symmetry along [010]. C—H⋯O interactions form an extended network.

Funding source: Umm Al-Qura University

Award Identifier / Grant number: 17MED-1-03-0007

Funding statement: Funding for this research was provided by: Deanship of Scientific Research at Umm Al-Qura University (Grant No. 17MED-1-03-0007 to Alaa Alqahtani).

Acknowledgements

The authors thank Umm Al-Qura and Cardiff Universities for their continuous support.

References

1. Rigaku Oxford Diffraction: CrysAlisPRO. Rigaku Oxford Diffraction, Yarnton, England (2015).Search in Google Scholar

2. Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Search in Google Scholar PubMed

3. Sheldrick, G. M.: Crystal structure refinement with SHELXL. Acta Crystallogr. C71 (2015) 3–8.10.1107/S2053229614024218Search in Google Scholar PubMed PubMed Central

4. Farrugia, L. J.: WinGX and ORTEP for Windows: an update. J. Appl. Crystallogr. 45 (2012) 849–854.10.1107/S0021889812029111Search in Google Scholar

5. Huck, J.; Saladin, R.; Sierra, M.; Klotz, E.: Modulation of peroxisome proliferator activated receptors activity. PCT Int. Appl. (2004) WO 2004/037248 A2.Search in Google Scholar

6. Karrouchi, K.; Radi, S.; Ramli, Y.; Taoufik, J.; Mabkhot, Y. N.; Al-Aizari, F. A.; Ansar, M.: Synthesis and pharmacological activities of pyrazole derivatives: a review. Molecules 23 (2018) 134.10.3390/molecules23010134Search in Google Scholar PubMed PubMed Central

7. Ganguly, S.; Jacob, S. K.: Therapeutic outlook of pyrazole analogs: a mini review. Mini-Rev. Med. Chem. 17 (2017) 959–983.10.2174/1389557516666151120115302Search in Google Scholar PubMed

8. Faria, J. V.; Vegi, P. F.; Miguita, A. G. C.; Dos Santos, M. S.; Boechat, N.; Bernardino, A. M. R.: Recently reported biological activities of pyrazole compounds. Bioorg. Med. Chem. 25 (2017) 5891–5903.10.1016/j.bmc.2017.09.035Search in Google Scholar PubMed

9. Naim, M. J.; Alam, O.; Nawaz, F.; Alam, M. J.; Alam, P.: Current status of pyrazole and its biological activities. J. Pharm. Bioall. Sci. 8 (2016) 2–17.10.4103/0975-7406.171694Search in Google Scholar PubMed PubMed Central

10. Khan, M. F.; Alam, M. M.; Verma, G.; Akhtar, W.; Akhter, M.; Shaquiquzzaman, M.: The therapeutic voyage of pyrazole and its analogs: a review. Eur. J. Med. Chem. 120 (2016) 170–201.10.1016/j.ejmech.2016.04.077Search in Google Scholar PubMed

11. Wen, J.; Fu, Y.; Hang, R.-Y.; Zhang, J.; Chen, S.-Y.; Yu, X.-Q.: A simple and efficient synthesis of pyrazoles in water. Tetrahedron 67 (2011) 9618–9621.10.1016/j.tet.2011.09.074Search in Google Scholar

12. Sun, A.; Ye, J.-H.; Yu, H.; Zhang, W.; Wang, X.: A new efficient synthesis of pyrazoles from hydrazonoyl halides and β-oxophosphonates. Tetrahedron Lett. 55 (2014) 889–892.10.1016/j.tetlet.2013.12.045Search in Google Scholar

13. Maddila, S.; Jonnalagadda, S. B.; Gangu, K. K.; Maddila, S. N.: Recent advances in the synthesis of pyrazole derivatives using multicomponent reactions. Curr. Org. Chem. 14 (2017) 634–653.10.2174/1570179414666161208164731Search in Google Scholar

14. El-Hiti, G. A.; Abdel-wahab, B. F.; Hegazy, A. S.; Alamri, M.; Kariuki, B. M.: Crystal structure of 2-((3-(5-methyl-1-phenyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazol-4-yl)methylene)-1H-indene-1,3(2H)-dione, C28H19N5O2. Z. Kristallogr. NCS 232 (2017) 19–20.10.1515/ncrs-2016-0108Search in Google Scholar

Received: 2019-03-13
Accepted: 2019-04-17
Published Online: 2019-05-17
Published in Print: 2019-09-25

©2019 Alaa Alqahtani et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 Public License.

Articles in the same Issue

  1. Frontmatter
  2. Crystal structure of poly[diaqua-(μ8-1,1′:2′,1′′-terphenyl-3,3′′,4′,5′-tetracarboxylato-κ8O1:O2:O3:O4:O5:O6:O7:O8)dicopper(II)], C22H14Cu2O10
  3. Crystal structure of 2-((1H-benzo[d]imidazol-2-ylimino)methyl)-4,6-di-tert-butylphenol, C22H27N3O
  4. Crystal structure of (4-ethoxynaphthalen-1-yl)(furan-2-yl)methanone, C17H14O3
  5. Crystal structure of 1-nonylpyridazin-1-ium iodide, C13H23N2I
  6. Crystal structure of bis[diaqua(1,10-phenanthroline-κ2N, N′)-copper(II)]diphenylphosphopentamolybdate dihydrate, C36H38Cu2Mo5N4O27P2
  7. The crystal structure of tetrakis(imidazole)-copper(I) hexafluorophosphate, C12H16CuF6PN8
  8. The crystal structure of dimethyl ((3,5-di-tert-butyl-4-hydroxyphenyl)(phenyl)methyl)phosphonate, C23H33O4P
  9. Crystal structure of diaqua-bis(1,10-phenanthroline κ2N,N′)nickel(II) trifluoroacetate- trifluoroacetic acid (1/1), C30H21F9N4NiO8
  10. Crystal structure of 2-(naphthalen-2-yl)-1,8-naphthyridine, C18H12N2
  11. Synthesis and crystal structure of a new polymorph of diisopropylammonium trichloroacetate, C8H16Cl3NO2
  12. Crystal structure of dimethanol-bis(1-((2-methyl-1H-benzo[d]imidazol-1-yl)methyl)-1H-benzo[d][1,2,3]triazole-κN)-bis(thiocyanato-κN)cadmium(II) C34H34CdN12O2S2
  13. Crystal structure of ethyl 2,2-difluoro-2-(7-methoxy-2-oxo-2H-chromen-3-yl)acetate, C14H12F2O5
  14. The crystal structure of bis[μ2-(N,N-diethylcarbamodithioato-κSSS′)] bis[1′-(diphenylphosphino-κP)-1-cyanoferrocene]disilver(I), C56H56Ag2Fe2N4P2S4
  15. Crystal structure of bis(di-n-butylammonium) tetrachloridodiphenylstannate(IV), C28H50Cl4N2Sn
  16. The crystal structure of poly[(μ5-2-((5-bromo-3-formyl-2-hydroxybenzylidene)amino)benzenesulfonato-κ6O:O:O,O′:O′:O′′)sodium(I)], C13H9O4NSBrNa
  17. Crystal structure of catena-{poly[bis(O,O′-diethyldithiophosphato-S)-(μ2-1,2-bis(4-pyridylmethylene)hydrazine-N,N′)-zinc(II)] di-acetonitrile solvate}, {C20H30N4O4P2S4Zn ⋅ 2 C2H3N}n
  18. Halogen and hydrogen bonding in the layered crystal structure of 2-iodoanilinium triiodide, C6H7I4N
  19. Crystal structure of cyclohexane-1,4-diammonium 2-[(2-carboxylatophenyl)disulfanyl]benzoate — dimethylformamide — monohydrate (1/1/1), [C6H16N2][C14H8O4S2] ⋅ C3H7NO⋅H2O
  20. The synthesis and crystal structure of isobutyl 5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-4-((trifluoromethyl)sulfinyl)-1H-pyrazole-3-carboxylate, C16H13Cl2F6N3O3S
  21. Isolation and crystal structure of bufotalinin — methanol (1/1), C25H34O7
  22. Crystal structure of benzylbis(1,3-diphenylpropane-1,3-dionato-κ2O,O′) chloridotin(IV), C37H29ClO4Sn
  23. Crystal structure of Bis{1-[(benzotriazol-1-yl)methyl]-1-H-1,3-(2-methyl-imidazol)}diiodidocadmium(II), [Cd(C11H11N5)2I2], C22H22N10I2Cd
  24. Crystal structure of 4-isobutoxybenzaldehyde oxime, C11H15NO2
  25. The crystal structure of bis(acetato-κ1O)-bis(N′-hydroxypyrimidine-2-carboximidamide-κ2N,N′)manganese(II) — methanol (1/2), C14H18MnN8O6, 2(CH3OH)′
  26. Crystal structure of poly[bis(μ2-bis(4-(1H-imidazol-1-yl)phenyl)amine-κ2N:N′)-bis(nitrato-κO)cadmium(II)], C36H30CdN12O6
  27. Crystal structure and optical properties of 1,6-bis(methylthio)pyrene, C18H14S2
  28. The crystal structure of hexaquamagnesium(II) bis(3,4-dinitropyrazol-1-ide), C6H14MgN8O14
  29. Halogen bonds in the crystal structure of 4,3:5,4-terpyridine – 1,4-diiodotetrafluorobenzene (1/1), C21H11F4I2N3
  30. Crystal structure and photochromic properties of a novel photochromic perfluordiarylethene containing a triazole bridged pyridine group moiety, C24H18F6N4S2
  31. Crystal structure of bis[(μ3-oxido)-(μ2-(N,N-diisopropylthiocarbamoylthio) acetato-κ2O,O′)-((N,N-diisopropylthiocarbamoylthio)acetato-κO)-bis(di-4-methylbenzyl-tin(IV))], C100H136N4O10S8Sn4
  32. Crystal structure of dibromidobis(4-bromobenzyl)tin(IV), C14H12Br4Sn
  33. The crystal structure of (4Z)-2-[(E)-(1-ethyl-3,3-dimethyl-1,3-dihydro-2H-indol-2-ylidene)methyl]-4-[(1-ethyl-3,3-dimethyl-3H-indolium-2-yl)methylidene]-3-oxocyclobut-1-en-1-olate, C30H32N2O2
  34. The crystal structure of (E)-3-(4-(dimethylamino)styryl)-5,5-dimethylcyclohex-2-en-1-one, C18H23NO
  35. Crystal structure of dihydrazinium 1H-pyrazole-3,5-dicarboxylate, C5H12N6O4
  36. Crystal structure of poly[μ2-1,4-bis((1H-imidazol-1-yl)methyl)benzene-κ2N:N′)-(μ2-4-sulfidobenzoate-κ2O:S)cobalt(II)] dihydrate, C42H44Co2N8O7S2
  37. Crystal structure of 8-(3,4-dimethylbenzylidene)-6,10-dioxaspiro[4.5]decane-7,9-dione, C17H18O4
  38. Crystal structure of 4-(2-bromo-4-(6-morpholino-3-phenyl-3H-benzo[f]chromen-3-yl) cyclohexa-2,5-dien-1-yl)morpholine, C33H31BrN2O
  39. Synthesis and crystal structure of 2-((1-phenyl-3-(thiophen-2-yl)-1H-pyrazol-4-yl)methylene)-2,3-dihydro-1H-inden-1-one, C23H16N2OS
  40. Crystal structure of poly[(μ2-1,1′-(oxybis(4,1-phenylene)bis(1H-imidazole)-κ2N,N′)(μ2-1,3-benzenecarboxylato-κ3O,O′:O′′)zinc(II)] dihydrate, C26H22N4O7Zn
  41. Crystal structure of diaqua-bis(cinnamato-κ2O,O′)zinc(II), C18H18ZnO6
  42. Crystal structure of 2-(prop-2-yn-1-yloxy)-1-naphthaldehyde, C14H10O2
  43. Crystal structure and photochromic properties of 1-(2-methyl-5-phenyl-3-thienyl)-2-{2-methyl-5-[4-(9-fluorenone hydrazone)-phenyl]-3-thienyl}perfluorocyclopentene, C41H26F6N2S2
  44. Hydrothermal synthesis and crystal structure of cylo[tetraaqua-bis(μ2-1,4-bis(1H-benzo[d]imidazol-1-yl)but-2-ene-κ2N:N′)-bis(μ2-4-nitro-phthalate-κ2O,O′)dinickel(II)], C26H23N5O8Ni
  45. Crystal structure of 3-[methyl(phenyl)amino]-1-phenylthiourea, C14H15N3S
  46. Crystal structure of 1-(4-chlorophenyl)-3-[methyl(phenyl)amino]thiourea, C14H14ClN3S
  47. Crystal structure of 2-tert-butyl-1H-imidazo[4,5-b]pyridine, C10H13N3
  48. Crystal structure of 5-carboxy-2-(2-carboxyphenyl)-1H-imidazol-3-ium-4-carboxylate dihydrate, C12H8N2O6⋅2(H2O)
  49. The crystal structure of dichlorido-μ2-dichlorido-(η2-1,4-bis(4-vinylbenzyl)-1,4-diazabicyclo[2.2.2]octane-1,4-diium)dicopper(I), C24H30N2Cu2Cl4
  50. Crystal structure of 4-bromobenzyl (Z)-N-(adamantan-1-yl)morpholine-4-carbothioimidate, C22H29BrN2OS
  51. Crystal structure of (4S,4aS,6aR,6bR,12aS,12bR,14aS,14bR)-3,3,6a,6b,9,9,12a-heptamethyloctadecahydro-1H,3H-4,14b-ethanophenanthro[1,2-h]isochromene-1(6bH)-one, C30H48O2
  52. Crystal structure of 3,5-bis(trifluoromethyl)benzyl (Z)-N′-(adamantan-1-yl)-4-phenylpiperazine-1-carbothioimidate, C30H33F6N3S
  53. The crystal structure of 3-methoxyphenanthridin-6(5H)-one, C14H11NO2
  54. Crystal structure of 4-(5,5-difluoro-1,3,7,9-tetramethyl-3H,5H-5λ4-dipyrrolo[1,2-c:2′,1′-f][1,3,2]diazaborinin-10-yl)pyridin-1-ium tetraiodidoferrate(III), C18H19BF2FeI4N3
  55. Crystal structure of 2-(3-methoxyphenyl)-3-((phenylsulfonyl)methyl)imidazo[1,2-a]pyridine, C21H18N2O3S
  56. Crystal structure of [(2-(2-chlorophenyl)-5-ethyl-1,3-dioxane-5-carboxylato-κ2O,O′) (5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)]nickel(II) perchlorate, C29H50Cl2N4NiO8
  57. Crystal structure of (Z)-6-(dimethylamino)-3,3-bis(4-(dimethylamino)phenyl)-2-(2-(quinoxalin-2-ylmethylene)hydrazinyl)-2,3-dihydroinden-1-one, C35H35N7O
  58. 5-Methyl-N′-[5-methyl-1-(4-methylphenyl)-1H-1,2,3-triazole-4-carbonyl]-1-(4-methylphenyl)-1H-1,2,3-triazole-4-carbohydrazide, C22H22N8O2
  59. Crystal structure of 2,3-dichloro-6-methoxyquinoxaline, C9H6Cl2N2O
  60. Synthesis and crystal structure of 7-chloro-2-(ethylsulfinyl)-6-fluoro-3-(1H-pyrazole-1-yl)-4H-thiochromen-4-one, C13H10FN3OS2
  61. Crystal structure of 4-ethylpiperazine-1-carbothioic dithioperoxyanhydride, C14H26N4S4
  62. Crystal structure of 2-(2-(6-methylpyridin-2-yl)naphthalen-1-yl)pyrimidine, C20H15N3
  63. The crystal structure of N′-((1E,2E)-4-(7-methoxy-2-oxo-2H-chromen-8-yl)-2-methylbut-2-en-1-ylidene)-3-methylbenzohydrazide, C23H22N2O4
  64. Crystal structure of catena-poly[(μ2-isophthalato-κ2O:O′)-(2,5-di(pyrazin-2-yl)-4,4′-bipyridine-κ3N,N′,N′′)zinc(II)] — water (2/5), C26H21N6O6.5Zn
  65. Crystal structure of (3E,5E)-3,5-bis(3-nitrobenzylidene)-1-((4-(trifluoromethyl)phenyl)sulfonyl)piperidin-4-one — dichloromethane (2/1), C53H38Cl2F6N6O14S2
  66. Crystal structure of (μ2-oxido)-bis(N,N′-o-phenylenebis(salicylideneiminato))diiron(III) — N,N′-dimethylformamide, C47H43Fe2N4O9
  67. Crystal structure of N1,N3-bis(2-hydroxyethyl)-N1, N1,N3,N3-tetramethylpropane-1,3-diaminium dibromide, C11H28Br2N2O2
  68. Crystal structure of (E)-N-(4-chlorophenyl)-1-(pyridin-2-yl)methanimine, C12H9ClN2
  69. Crystal structure of 8-bromo-6-oxo-2-phenyl-6H-pyrrolo[3,2,1-ij]quinoline-5-carbaldehyde, C18H11BrNO2
  70. Crystal structure of 1,4-bis(2-azidoethyl)piperazine-1,4-diium dichloride trihydrate, C8H18N8Cl2 ⋅ 3 H2O
  71. Crystal structure of (E)-4-bromo-N-(pyridin-2-ylmethylene)aniline, C12H9BrN2
  72. Crystal structure of bis[(2-(3-bromophenyl)-5-methyl-1,3-dioxane-5-carboxylato-κ-O)-(5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)]nickel(II), C40H60Br2N4NiO8
  73. The crystal structure of (1E,2E)-2-methyl-4-((7-oxo-7H-furo[3,2-g]chromen-9-yl)oxy)but-2-enal O-isonicotinoyl oxime–trichloromethane (3/1), C67H49Cl3N6O18
  74. Crystal structure of 3-(2-ethoxy-2-oxoethyl)-1-methyl-1H-imidazol-3-ium hexafluoridophosphate(V), C8H13F6N2O2P
  75. Crystal structure of bis[(2-(2-bromophenyl)-5-ethyl-1,3-dioxane-5-carboxylato-κO)-(5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)]nickel(II) hemihydrate C42H65Br2N4NiO8.5
  76. The crystal structure of N-(7-(4-fluorobenzylidene)-3-(4-fluorophenyl)-3,3a,4,5,6,7-hexahydro-2H-indazole-2-carbonothioyl)benzamide, C28H23F2N3OS
  77. The crystal structure of N1,N4-bis(pyridin-3-yl)cyclohexane-1,4-dicarboxamide, C18H20N4O2
  78. Crystal structure of (E)-2-(3,6-bis(ethylamino)-2,7-dimethyl-9H-xanthen-9-yl)-N′-((6-methylpyridin-2-yl)methylene)benzohydrazide – methanol (1/1), C34H37N5O3
  79. Crystal structure of 2-oxo-1-(pyrimidin-5-ylmethyl)-3-(3-(trifluoromethyl)phenyl)-1,2-dihydro-5l4-pyrido[1,2-a]pyrimidin-4-olate, C20H13F3N4O2
  80. Crystal structure of poly[(μ3-9H-carbazole-3,6-dicarboxylato-κ3O1: O2: O3)(μ2-4-(pyridin-4-yl)pyridine-κ2N1:N1′)zinc(II)], C19H11N2O4Zn
  81. Crystal structure of (E)-N′-((1,8-dihydropyren-1-yl)-methylene)picolinohydrazide, C23H15N3O
  82. Crystal structure of catena-poly{[μ2-1,2-bis(diphenylphosphino)ethane]dichloridocadmium(II)}, C26H24CdCl2P2
  83. Crystal structure of the 1:2 co-crystal between N,N′-bis(4-pyridylmethyl)oxalamide and acetic acid as a dihydrate, C14H14N4O2⋅2 C2H4O2⋅2 H2O
  84. Crystal structure of the co-crystal N,N′-bis(3-pyridylmethyl)oxalamide acetic acid (1/2), C14H14N4O2⋅2C2H4O2
  85. Crystal structure of the co-crystal N,N′-bis(4-pyridylmethyl)oxalamide and 2,3,5,6-tetrafluoro-1,4-di-iodobenzene (1/1), C14H14N4O2⋅C6F4I2
  86. Crystal structure of the co-crystal 4-[(4-carboxyphenyl)disulfanyl]benzoic acid–(1E,4E)-1-N,4-N-bis(pyridin-4-ylmethylidene)cyclohexane-1,4-diamine (1/1), C14H10O4S2⋅C18H20N4
  87. Crystal structure of hexacarbonyl-bis(μ2-di-n-propyldithiocarbamato-κ3S,S′:S3S:S:S′)-di-rhenium(I), C20H28N2O6Re2S4
  88. Crystal structure of fac-tricarbonyl-morpholine-κN-(morpholinocarbamodithioato-κ2S,S′)rhenium(I), C12H17N2O5ReS2
Downloaded on 30.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2019-0189/html
Scroll to top button